SFS
EPZM

Sowell Financial Services’s Epizyme, Inc EPZM Stock Holding History

Sowell Financial Services’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,052
Closed -$7K – 3075
2021
Q1 		$7K Buy
1,052
+332
+46% +$3.44K ﹤0.01% 2499
2020
Q4 		$8K Buy
720
+562
+356% +$6.93K ﹤0.01% 2140
2020
Q3 		$2K Sell
158
-168
-52% -$2.25K ﹤0.01% 2301
2020
Q2 		$5K Buy
+326
New +$5.69K ﹤0.01% 1929
2020
Q1 		– Sell
-3,441
Closed -$85K – 2783
2019
Q4 		$85K Buy
+3,441
New +$51.1K 0.01% 968

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Sowell Financial Services's EPZM Position: Q2 2021 in Review

Sowell Financial Services sold out of Epizyme, Inc (EPZM) in Q2 2021, closing a stake of 1,052 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in EPZM in Q4 2019 and held it in 5 quarters. The position peaked at $85K in Q4 2019. 127 funds tracked by Wall St. Rank hold EPZM as of Q2 2021.

  • Sowell Financial Services reported no remaining Epizyme, Inc position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,052 Epizyme, Inc shares in Q2 2021, an estimated $7K.
  • Sowell Financial Services first reported a position in Epizyme, Inc in Q4 2019 and held it in 5 quarters.
  • Sowell Financial Services's Epizyme, Inc position peaked at $85K in Q4 2019.
  • 127 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.